UNSPSC 51151652: Methscopolamine or methylscopolamine

This classification denotes an antimuscarinic agent with the molecular formula C18H24NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VDR09VTQ8U, chemically known as scopolammonium, n-methylbromide but generally known as methscopolamine, which bears US NIH Compound Identifier 441342. European Medicines Agency schedules Methscopolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32123. Methscopolamine or methylscopolamine bears US NLM identifiers UMLS ID C0301374 and NCI Concept Code C76001.

SMILES: BR.O1C2C3[N](C(C12)CC(OC(=O)C(CO)C1CCCCC1)C3)(C)C.

UNSPSC 51151652 Methscopolamine or methylscopolamine is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The two recent opportunities posted under this code — a Seminole County, Florida IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2023) and a Texas Health and Human Services Commission RFI for direct-to-manufacturer pharmacy programs (HHS0017013, posted April 3, 2026) — are substantially unrelated to the purchase of methscopolamine or methylscopolamine as pharmaceutical products. The naloxone solicitation addresses emergency medical countermeasures and harm reduction, while the Texas RFI concerns pharmacy benefit program structure and prescription fulfillment logistics, neither of which involves the specific active pharmaceutical ingredient this code nominally covers.

State and local procurement activity under this code does not support a clear market signal. The mismatch between the code's pharmaceutical specificity and the actual work being solicited suggests either miscoding within state and local procurement systems or that methscopolamine and methylscopolamine are purchased so infrequently or in such small volumes through standard pharmaceutical supply channels that they do not generate dedicated solicitations. No geographic concentration, repeat issuing bodies, or pattern of relevant recent opportunities emerges from the available record. Vendors evaluating this code should verify directly with prospective buying agencies whether methscopolamine or methylscopolamine procurement is anticipated and, if so, whether it will be solicited under a different UNSPSC code or bundled into broader pharmaceutical or medical supply contracts.